Docoh
Loading...

SGRY Surgery Partners

News

Pro users get this 30m faster
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2021
18 Oct 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Upgrades
SVB Leerink Initiates Coverage On Surgery Partners with Outperform Rating, Announces Price Target of $50
18 Oct 21
News, Price Target, Initiation, Analyst Ratings
SVB Leerink analyst Whit Mayo initiates coverage on Surgery Partners (NASDAQ:SGRY) with a Outperform rating and announces Price Target of $50.
Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021
10 Sep 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Cowen & Co. Initiates Coverage On Surgery Partners with Market Perform Rating, Announces Price Target of $50
10 Sep 21
News, Price Target, Initiation, Analyst Ratings
Cowen & Co. analyst Gary Taylor initiates coverage on Surgery Partners (NASDAQ:SGRY) with a Market Perform rating and announces Price Target of $50.
88 Biggest Movers From Yesterday
5 Aug 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
Surgery Partners: Q2 Earnings Insights
4 Aug 21
Earnings, News
Shares of Surgery Partners (NASDAQ:SGRY) fell 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the past year to $0.00, which beat the estimate of ($0.20).
Surgery Partners Q2 EPS $0.00 Beat $(0.20) Est., Sales $543.30M Beat $538.30M Estimate
4 Aug 21
Earnings, News
Surgery Partners (NASDAQ:SGRY) reported quarterly sales of $543.30 million which beat the analyst consensus estimate of $538.30 million by 0.93 percent. This is a 45.00 percent increase over sales of $374.70 million the
Earnings Scheduled For August 4, 2021
4 Aug 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.